Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Disease to Bone”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03304418
What this trial is testing

Radium-223 and Radiotherapy in Hormone-Naïve Men With Oligometastatic Prostate Cancer to Bone

Who this might be right for
Prostate Cancer Metastatic to Bone
University of Utah 20
Post-approval studies (Phase 4)Study completedNCT02553707
What this trial is testing

Assess the Short Term Efficacy of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Pain Due to Breast Cancer

Who this might be right for
Pain; Bone Neoplasms; Neoplasm Metastasis
Hoffmann-La Roche 182
Not applicableUnknownNCT06487013
What this trial is testing

Effectiveness and Safety of ArcBlate Palliative Treatment for Patients With Painful Bone Metastases: A Pivotal Study

Who this might be right for
Bone Metastases
EpiSonica 100
Early research (Phase 1)Study completedNCT03197623
What this trial is testing

Safety and Tolerability of Intravenous LLP2A-Alendronate for Osteopenia Secondary to Glucocorticoids

Who this might be right for
OsteopeniaOsteoporosisOsteonecrosis
Nancy E. Lane, MD 58
Not applicableStudy completedNCT00014482
What this trial is testing

Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell Transplantation

Who this might be right for
Anxiety DisorderChronic Myeloproliferative DisordersDepression+4 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT02029417
What this trial is testing

Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+14 more
Roswell Park Cancer Institute 2
Testing effectiveness (Phase 2)Study completedNCT00005795
What this trial is testing

Arsenic Trioxide in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Northwestern University 11
Not applicableEnded earlyNCT03579212
What this trial is testing

Evaluation of the Performance of Y-STRUT® Medical Device to Strengthen Pre-fractural Tumour-induced Lesions at the Level of the Proximal Femur

Who this might be right for
Pathological Fracture of HipBone Metastases
Hyprevention 16
Not applicableStudy completedNCT00899795
What this trial is testing

Evaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy Volunteers

Who this might be right for
LeukemiaMyelodysplastic Syndromes
OHSU Knight Cancer Institute 35
Not applicableStudy completedNCT00824213
What this trial is testing

Pilot Project: Fast Whole-body Spect Scanning to Improve the Detection of Bone Metastases in Patients With Diagnosed Cancer

Who this might be right for
Bone Metastases
University of British Columbia 50
Testing effectiveness (Phase 2)WithdrawnNCT00081055
What this trial is testing

OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
Mesoblast International Sàrl
Testing effectiveness (Phase 2)Study completedNCT01812252
What this trial is testing

Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant

Who this might be right for
Chronic Myelomonocytic Leukemiade Novo Myelodysplastic SyndromeMyelodysplastic Syndrome+1 more
Fred Hutchinson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT01414114
What this trial is testing

Etelcalcetide to Treat Secondary Hyperparathyroidism in Hemodialysis Patients With Chronic Kidney Disease-Mineral and Bone Disorder

Who this might be right for
Secondary Hyperparathyroidism
KAI Pharmaceuticals 37
Large-scale testing (Phase 3)UnknownNCT04550949
What this trial is testing

To Evaluate the Efficacy and Safety of QL1206 and Xgeva in Patients With Bone Metastases From Solid Tumors

Who this might be right for
Bone Metastases
Qilu Pharmaceutical Co., Ltd. 700
Early research (Phase 1)Study completedNCT00509691
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Who this might be right for
Cancer
University of Louisville 20
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06987058
What this trial is testing

RVU120 Rollover Study

Who this might be right for
Advanced Solid TumorsAcute Myeloid Leukaemia (AML)High-risk Myelodysplastic Syndrome
Ryvu Therapeutics SA 14
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00036790
What this trial is testing

Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more
University of Wisconsin, Madison
Early research (Phase 1)Study completedNCT00720785
What this trial is testing

Natural Killer Cells and Bortezomib to Treat Cancer

Who this might be right for
Chronic Myeloid Leukemia (CML)Pancreatic CaColon/Rectal Ca+2 more
National Heart, Lung, and Blood Institute (NHLBI) 35
Testing effectiveness (Phase 2)WithdrawnNCT01174537
What this trial is testing

New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma

Who this might be right for
GlioblastomaSarcomaNeuroblastoma
Hadassah Medical Organization
Next Page